熱門資訊> 正文
高达2.5亿美元的混合货架产品的器官生成文件
2024-08-09 06:26
- Organogenesis (NASDAQ:ORGO) on Thursday filed a prospectus about a mixed shelf offering of up to $250M and the selling stockholders may offer and sell up to 50M shares in the aggregate of Class A common stock.
- The company added that it will not receive any proceeds from the sale of its Class A common stock by the selling stockholders.
- The prospectus is not an offer to sell.
- SEC Filing.
More on Organogenesis Holdings
- Organogenesis Holdings: Small-Cap Biotech With Inconsistent Earnings And A Powerful Catalyst
- Organogenesis Holdings Q2 2024 Earnings Preview
- Seeking Alpha’s Quant Rating on Organogenesis Holdings
- Historical earnings data for Organogenesis Holdings
- Financial information for Organogenesis Holdings
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
